BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30917061)

  • 1. Identification of Novel Mast Cell Activators Using Cell-Based High-Throughput Screening.
    Choi HW; Chan C; Shterev ID; Lynch HE; Robinette TJ; Johnson-Weaver BT; Shi J; Sempowski GD; Kim SY; Dickson JK; Gooden DM; Abraham SN; Staats HF
    SLAS Discov; 2019 Jul; 24(6):628-640. PubMed ID: 30917061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal Immunization With Small Molecule Mast Cell Activators Enhance Immunity to Co-Administered Subunit Immunogens.
    Johnson-Weaver BT; Choi HW; Yang H; Granek JA; Chan C; Abraham SN; Staats HF
    Front Immunol; 2021; 12():730346. PubMed ID: 34566991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Combination of Screening and Computational Approaches for the Identification of Novel Compounds That Decrease Mast Cell Degranulation.
    McShane MP; Friedrichson T; Giner A; Meyenhofer F; Barsacchi R; Bickle M; Zerial M
    J Biomol Screen; 2015 Jul; 20(6):720-8. PubMed ID: 25838434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cinnamon extract inhibits degranulation and de novo synthesis of inflammatory mediators in mast cells.
    Hagenlocher Y; Bergheim I; Zacheja S; Schäffer M; Bischoff SC; Lorentz A
    Allergy; 2013 Apr; 68(4):490-7. PubMed ID: 23409834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRGPRX2 activation as a rapid, high-throughput mechanistic-based approach for detecting peptide-mediated human mast cell degranulation liabilities.
    Lafleur MA; Werner J; Fort M; Lobenhofer EK; Balazs M; Goyos A
    J Immunotoxicol; 2020 Dec; 17(1):110-121. PubMed ID: 32525431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses.
    Smrž D; Bandara G; Zhang S; Mock BA; Beaven MA; Metcalfe DD; Gilfillan AM
    J Immunol Methods; 2013 Apr; 390(1-2):52-62. PubMed ID: 23357051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of Perivascular Mast Cells by Endothelial CNP (C-Type Natriuretic Peptide).
    Chen W; Werner F; Illerhaus A; Knopp T; Völker K; Potapenko T; Hofmann U; Frantz S; Baba HA; Rösch M; Zernecke A; Karbach S; Wenzel P; Kuhn M
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):682-696. PubMed ID: 31893950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoids limit excessive mast cell maturation and activation in human skin.
    Sugawara K; Bíró T; Tsuruta D; Tóth BI; Kromminga A; Zákány N; Zimmer A; Funk W; Gibbs BF; Zimmer A; Paus R
    J Allergy Clin Immunol; 2012 Mar; 129(3):726-738.e8. PubMed ID: 22226549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phenotypic screening approach in cord blood-derived mast cells to identify anti-inflammatory compounds.
    Kaur R; Sloan LA; Blanchard AD; Smith JL; Churcher I; Wayne GJ; Ludbrook SB
    J Biomol Screen; 2013 Dec; 18(10):1223-33. PubMed ID: 23983232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-Molecule Host-Defense Peptide Mimetic Antibacterial and Antifungal Agents Activate Human and Mouse Mast Cells via Mas-Related GPCRs.
    Alkanfari I; Freeman KB; Roy S; Jahan T; Scott RW; Ali H
    Cells; 2019 Apr; 8(4):. PubMed ID: 30987258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells.
    Magerl M; Lammel V; Siebenhaar F; Zuberbier T; Metz M; Maurer M
    Exp Dermatol; 2008 May; 17(5):427-35. PubMed ID: 18331331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antipsychotic drug pimozide inhibits IgE-mediated mast cell degranulation and migration.
    Hou YB; Zhang LN; Wang HN; Zhao ZF; Sun YT; Ji K; Chen JJ
    Int Immunopharmacol; 2020 Jul; 84():106500. PubMed ID: 32311669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetraspanins in the regulation of mast cell function.
    Orinska Z; Hagemann PM; Halova I; Draber P
    Med Microbiol Immunol; 2020 Aug; 209(4):531-543. PubMed ID: 32507938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum- and glucocorticoid-inducible kinase SGK1 regulates reorganization of actin cytoskeleton in mast cells upon degranulation.
    Schmid E; Gu S; Yang W; Münzer P; Schaller M; Lang F; Stournaras C; Shumilina E
    Am J Physiol Cell Physiol; 2013 Jan; 304(1):C49-55. PubMed ID: 23015548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic Insights of an Immunological Adverse Event Induced by an Anti-KIT Antibody Drug Conjugate and Mitigation Strategies.
    L'Italien L; Orozco O; Abrams T; Cantagallo L; Connor A; Desai J; Ebersbach H; Gelderblom H; Hoffmaster K; Lees E; Maacke H; Schleyer S; Skegro D; Lee-Hoeflich ST
    Clin Cancer Res; 2018 Jul; 24(14):3465-3474. PubMed ID: 29615457
    [No Abstract]   [Full Text] [Related]  

  • 16. The tetraspanin CD63 is required for efficient IgE-mediated mast cell degranulation and anaphylaxis.
    Kraft S; Jouvin MH; Kulkarni N; Kissing S; Morgan ES; Dvorak AM; Schröder B; Saftig P; Kinet JP
    J Immunol; 2013 Sep; 191(6):2871-8. PubMed ID: 23945142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses.
    Oskeritzian CA; Hait NC; Wedman P; Chumanevich A; Kolawole EM; Price MM; Falanga YT; Harikumar KB; Ryan JJ; Milstien S; Sabbadini R; Spiegel S
    J Allergy Clin Immunol; 2015 Apr; 135(4):1008-1018.e1. PubMed ID: 25512083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism.
    Brown JM; Nemeth K; Kushnir-Sukhov NM; Metcalfe DD; Mezey E
    Clin Exp Allergy; 2011 Apr; 41(4):526-34. PubMed ID: 21255158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
    Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
    J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release.
    Hermans MAW; Schrijver B; van Holten-Neelen CCPA; Gerth van Wijk R; van Hagen PM; van Daele PLA; Dik WA
    Clin Exp Allergy; 2018 Nov; 48(11):1412-1420. PubMed ID: 29939445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.